210 related articles for article (PubMed ID: 8163716)
1. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
Kraisinger M; Hochhaus G; Stecenko A; Bowser E; Hendeles L
J Clin Pharmacol; 1994 Feb; 34(2):158-66. PubMed ID: 8163716
[TBL] [Abstract][Full Text] [Related]
2. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Dutta SK; Hubbard VS; Appler M
Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
[TBL] [Abstract][Full Text] [Related]
3. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
[TBL] [Abstract][Full Text] [Related]
4. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
Regele S; Henker J; Münch R; Barbier Y; Stern M
J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
[No Abstract] [Full Text] [Related]
6. Pancreatic enzyme pharmacotherapy.
Ferrone M; Raimondo M; Scolapio JS
Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
Zylberberg P; Delchier JC
Gastroenterol Clin Biol; 1993; 17(11):816-22. PubMed ID: 8143947
[No Abstract] [Full Text] [Related]
9. [Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].
Braggion C; Mastella G
Minerva Pediatr; 1985 Nov; 37(21-22):891-6. PubMed ID: 3912659
[No Abstract] [Full Text] [Related]
10. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better".
Lebenthal E
J Pediatr Gastroenterol Nutr; 1994 May; 18(4):423-5. PubMed ID: 8071775
[No Abstract] [Full Text] [Related]
11. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
Löser C; Fölsch UR
Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
[TBL] [Abstract][Full Text] [Related]
12. Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis.
Carroccio A; Pardo F; Montalto G; Iapichino L; Soresi M; Averna MR; Iacono G; Notarbartolo A
Dig Dis Sci; 1992 Sep; 37(9):1441-6. PubMed ID: 1505293
[TBL] [Abstract][Full Text] [Related]
13. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
Gottschalk B; Wiesemann HG; Stephan U
Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
[TBL] [Abstract][Full Text] [Related]
16. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
[TBL] [Abstract][Full Text] [Related]
17. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
Layer P; Gröger G
Digestion; 1993; 54 Suppl 2():10-4. PubMed ID: 7693530
[TBL] [Abstract][Full Text] [Related]
18. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
Zerega J; Lerner S; Meyer JH
Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
Heubi JE; Schaeffer D; Ahrens RC; Sollo N; Strausbaugh S; Graff G; Jain R; Witte S; Forssmann K
J Pediatr; 2016 Sep; 176():156-161.e1. PubMed ID: 27297209
[TBL] [Abstract][Full Text] [Related]
20. A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.
Littlewood JM; Connett GJ; Sander-Struckmeier S; Henniges F;
Expert Opin Drug Saf; 2011 Mar; 10(2):197-203. PubMed ID: 21342076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
